Corbus Pharmaceuticals Holdings Inc logo

Corbus Pharmaceuticals Holdings Inc

2
NAS:CRBP (USA)  
$ 6.61 +1.84 (+37.94%) 10:08 PM EST
At Loss
P/B:
69.29
Market Cap:
$ 29.24M
Enterprise V:
$ 23.36M
Volume:
46.31K
Avg Vol (2M):
14.27K
Also Trade In:
Volume:
46.31K
At Loss
Avg Vol (2M):
14.27K

Business Description

Corbus Pharmaceuticals Holdings Inc logo
Corbus Pharmaceuticals Holdings Inc
NAICS : 325414 SIC : 2834
ISIN : US21833P1030
Description
Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune systems. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. Corbus' internal development pipeline includes CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells.
Name Current Vs Industry Vs History
Cash-To-Debt 1.26
Equity-to-Asset 0.01
Debt-to-Equity 73.5
Debt-to-EBITDA -0.6
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 89.31
9-Day RSI 78
14-Day RSI 69.11
6-1 Month Momentum % -42.45
12-1 Month Momentum % -6.6

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.99
Quick Ratio 0.99
Cash Ratio 0.91

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -24.6
Shareholder Yield % 6.19

Profitability Rank

Name Current Vs Industry Vs History
ROE % -234.43
ROA % -87.31
ROIC % -263.18
ROC (Joel Greenblatt) % -772.64
ROCE % -110.47

Financials (Next Earnings Date:2024-03-07 Est.)

CRBP's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CRBP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Corbus Pharmaceuticals Holdings Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -11.17
Beta 2.61
Volatility % 168.74
14-Day RSI 69.11
14-Day ATR ($) 0.635189
20-Day SMA ($) 4.373
12-1 Month Momentum % -6.6
52-Week Range ($) 2.11 - 13.1699
Shares Outstanding (Mil) 4.42

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Corbus Pharmaceuticals Holdings Inc Filings

Filing Date Document Date Form
No Filing Data

Corbus Pharmaceuticals Holdings Inc Stock Events

Event Date Price($)
No Event Data

Corbus Pharmaceuticals Holdings Inc Frequently Asked Questions

What is Corbus Pharmaceuticals Holdings Inc(CRBP)'s stock price today?
The current price of CRBP is $6.61. The 52 week high of CRBP is $13.17 and 52 week low is $2.11.
When is next earnings date of Corbus Pharmaceuticals Holdings Inc(CRBP)?
The next earnings date of Corbus Pharmaceuticals Holdings Inc(CRBP) is 2024-03-07 Est..
Does Corbus Pharmaceuticals Holdings Inc(CRBP) pay dividends? If so, how much?
Corbus Pharmaceuticals Holdings Inc(CRBP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1